Market Overview

Perrigo Buys Remaining Stake in Cobrek Pharma for ~$45M

Share:
Related PRGO
Where There's Smoke, There's Not Always Fire: Be Careful With These 10 Rumor Mill Stocks
Wall Street's M&A Chatter From January 19
Dividend Contenders: 43 Increases Expected By The End Of March (Seeking Alpha)

Perrigo Company (Nasdaq: PRGO) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek Pharmaceuticals, Inc. (Cobrek), a privately-held, Chicago, Illinois-based drug development company, for approximately $45 million on a cash free and debt free basis.

Posted-In: News M&A

 

Related Articles (PRGO)

View Comments and Join the Discussion!